Altimmune announces third quarter 2020 financial results and provides a business update

Gaithersburg, md., nov. 09, 2020 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced financial results for the three and nine months ended september 30, 2020 and provided a business update.

ALT Ratings Summary

ALT Quant Ranking